Clinical Trials Directory

Trials / Completed

CompletedNCT04784013

Very High Power Ablation in Patients With Atrial Fibrillation Scheduled for a First Pulmonary Vein Isolation

Very High Power Ablation in Patients With Atrial Fibrillation Scheduled for a First Pulmonary Vein Isolation: the POWER-PLUS Study

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
182 (actual)
Sponsor
AZ Sint-Jan AV · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This prospective, randomized, controlled, unblinded, multicenter study aims at comparing procedural time between conventional CLOSE-guided pulmonary vein isolation (PVI) (35W/50W) versus very high power radiofrequency delivery (90W) in atrial fibrillation patients scheduled for a first PVI.

Conditions

Interventions

TypeNameDescription
PROCEDUREConventional CLOSE-guided pulmonary vein isolationPoint-by-point RF delivery will be performed aiming for a contiguous circle enclosing the veins. RF will be delivered in a temperature and flow-controlled mode (QMODE, target temperature 45°C, low flow temperature 40°C, cut-off temperature 50°C) with a power of 35W(posterior)/50W(anterior) (irrigation flow at 4-15ml/min). RF will be delivered until an ablation index (AI) of ≥400 at the posterior wall/roof/south pole and ≥550 at the anterior wall.
PROCEDUREHigh power short duration pulmonary vein isolationPoint-by-point RF delivery will be performed aiming for a contiguous circle enclosing the veins. RF will be delivered in temperature-controlled mode (QMode+, target temperature 55°C, cut-off temperature 65°C) with a power of 90W (irrigation flow at 2-8ml/min). RF will be delivered for 4 sec at both the posterior and anterior wall.

Timeline

Start date
2021-03-24
Primary completion
2021-10-22
Completion
2022-05-31
First posted
2021-03-05
Last updated
2022-06-21

Locations

4 sites across 4 countries: Austria, Belgium, Netherlands, Switzerland

Source: ClinicalTrials.gov record NCT04784013. Inclusion in this directory is not an endorsement.